Search - tctmd.com

Displaying 781 - 800 of 2689

Sort: Relevancy | Date

Presentation TCT 2019

State of the Art: Device-Based Therapies for Heart Failure and Reduced EF

Presenter: Nir Uriel

September 28, 2019

Presentation TCT 2019

State of the Art: Current and Future of Medical Therapies for HF

Presenter: Clyde Yancy

September 28, 2019

Presentation TCT 2019

What is the Role of the Interventional Cardiologist in Lipid Management?

Presenter: Wolfgang Koenig

September 28, 2019

Presentation TCT 2019

The State of The Art in LDL-C Lowering: Urgent Needs and Unmet Opportunities

Presenter: R. Wright

September 28, 2019

Presentation TCT 2019

The Angiogram: Charting the Course for Effective Lipid Management

Presenter: Ori Ben-Yehuda

September 28, 2019

Presentation TCT 2019

Social Media in the Modern Era of Interventional Cardiology

Presenter: M Chadi Alraies

September 28, 2019

Presentation TCT 2019

Future Challenges for Hypertension Therapies: My Crystal Ball for the Next 5-10 years

Presenter: Melvin Lobo

September 28, 2019

Presentation TCT 2019

Future Developments in Drug Delivery Technologies

Presenter: Robert Byrne

September 28, 2019

Presentation TCT 2019

Who is the Ideal Patient for an Interventional HTN Therapy

Presenter: Michel Azizi

September 28, 2019

Presentation TCT 2019

Aspirin Variability, Interactions and Impact of Different Formulations

Presenter: Dominick Angiolillo

September 28, 2019

Presentation TCT 2019

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Presenter: Sanjit Jolly

September 28, 2019

Presentation TCT 2019

The BTK Interventional Toolbox: Wires and Crossing Devices

Presenter: Ehrin Armstrong

September 28, 2019

Presentation TCT 2019

Interventional Therapies for Hypertension: Thinking Outside the Kidney

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

The Challenges and Hazards of Re-Intervention and Stenting

Presenter: David Kandzari

September 28, 2019

Presentation TCT 2019

Reducing Aspirin Use in ACS and PCI (With and Without AFib): How Good Is the Evidence?

Presenter: C. Michael Gibson

September 28, 2019

Presentation TCT 2019

Critical Analysis of De Novo and ISR Clinical Trial Data

Presenter: Fernando Alfonso

September 28, 2019

Presentation TCT 2019

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

The Changing Coronary Lesion Phenotype Requires a Different Set of Interventional Tools!

Presenter: Antonio Colombo

September 28, 2019

Advertisement

State of the Art: Device-Based Therapies for Heart Failure and Reduced EF

State of the Art: Current and Future of Medical Therapies for HF

What is the Role of the Interventional Cardiologist in Lipid Management?

The State of The Art in LDL-C Lowering: Urgent Needs and Unmet Opportunities

The Angiogram: Charting the Course for Effective Lipid Management

Social Media in the Modern Era of Interventional Cardiology

Future Challenges for Hypertension Therapies: My Crystal Ball for the Next 5-10 years

Future Developments in Drug Delivery Technologies

Who is the Ideal Patient for an Interventional HTN Therapy

Aspirin Variability, Interactions and Impact of Different Formulations

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

The BTK Interventional Toolbox: Wires and Crossing Devices

Interventional Therapies for Hypertension: Thinking Outside the Kidney

The Challenges and Hazards of Re-Intervention and Stenting

Reducing Aspirin Use in ACS and PCI (With and Without AFib): How Good Is the Evidence?

Critical Analysis of De Novo and ISR Clinical Trial Data

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

The Changing Coronary Lesion Phenotype Requires a Different Set of Interventional Tools!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content